A detailed history of M&G PLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, M&G PLC holds 228,211 shares of CORT stock, worth $14.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
228,211
Previous 242,901 6.05%
Holding current value
$14.5 Million
Previous $11.2 Billion 2.12%
% of portfolio
0.07%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$44.66 - $60.85 $656,055 - $893,886
-14,690 Reduced 6.05%
228,211 $11.4 Billion
Q3 2024

Oct 31, 2024

BUY
$29.51 - $46.26 $7.17 Million - $11.2 Million
242,901 New
242,901 $11.2 Billion

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.81B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track M&G PLC Portfolio

Follow M&G PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G PLC, based on Form 13F filings with the SEC.

News

Stay updated on M&G PLC with notifications on news.